These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 15989660)
21. Small and lethal: searching for new antibacterial compounds with novel modes of action. Pathania R; Brown ED Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624 [TBL] [Abstract][Full Text] [Related]
22. Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Bauer RA; Wurst JM; Tan DS Curr Opin Chem Biol; 2010 Jun; 14(3):308-14. PubMed ID: 20202892 [TBL] [Abstract][Full Text] [Related]
24. Structure-based generation of viable leads from small combinatorial libraries. Laird ER; Blake JF Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940 [TBL] [Abstract][Full Text] [Related]
25. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
26. Applications of structure-based design to antibacterial drug discovery. Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384 [TBL] [Abstract][Full Text] [Related]
27. Novel targets for the future development of antibacterial agents. McDevitt D; Payne DJ; Holmes DJ; Rosenberg M Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826 [TBL] [Abstract][Full Text] [Related]
28. Viable screening targets related to the bacterial cell wall. Silver LL Ann N Y Acad Sci; 2013 Jan; 1277():29-53. PubMed ID: 23278681 [TBL] [Abstract][Full Text] [Related]
29. Novel targets for the future development of antibacterial agents. McDevitt D; Payne DJ; Holmes DJ; Rosenberg M J Appl Microbiol; 2002; 92 Suppl():28S-34S. PubMed ID: 12000610 [TBL] [Abstract][Full Text] [Related]
30. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923 [TBL] [Abstract][Full Text] [Related]
31. Applied metabolomics in drug discovery. Cuperlovic-Culf M; Culf AS Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968 [TBL] [Abstract][Full Text] [Related]
32. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Lu H; Tonge PJ Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820 [TBL] [Abstract][Full Text] [Related]
33. Applications of biophysical tools to target-based discovery of novel antibacterial leads. Lahiri S; Kazmirski S; Kern G; Sanyal G Curr Drug Targets; 2012 Mar; 13(3):388-408. PubMed ID: 22206259 [TBL] [Abstract][Full Text] [Related]
34. Screening strategies for discovery of antibacterial natural products. Singh SB; Young K; Miesel L Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327 [TBL] [Abstract][Full Text] [Related]
35. Exploiting current understanding of antibiotic action for discovery of new drugs. Chopra I; Hesse L; O'Neill AJ Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824 [TBL] [Abstract][Full Text] [Related]
38. Balancing novelty with confined chemical space in modern drug discovery. Medina-Franco JL; Martinez-Mayorga K; Meurice N Expert Opin Drug Discov; 2014 Feb; 9(2):151-65. PubMed ID: 24350718 [TBL] [Abstract][Full Text] [Related]
39. Are natural products still the best source for antibacterial discovery? The bacterial entry factor. Silver LL Expert Opin Drug Discov; 2008 May; 3(5):487-500. PubMed ID: 23484922 [TBL] [Abstract][Full Text] [Related]
40. The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery. Barnes EC; Kumar R; Davis RA Nat Prod Rep; 2016 Mar; 33(3):372-81. PubMed ID: 26739749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]